eli lilly tirzepatide trial New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Zepbound bests Wegovy in head-to-head

Understanding GLP-1 Receptor Agonists Glucagon-like peptide-1 (GLP-1) receptor agonists are medications that mimic the action of the natural GLP-1 hormone in your body

Understanding Your Engagement Status: As part of your insurance companys requirements, please make sure to use your Omada app at least 4 times over the past 31 days and weigh yourself with the Omada scale at least 4 times in the last 31 days

What is the Myers Cocktail

Increased energy, better sleep, and improved immune function are additional benefits of these treatments, making them a well-rounded investment in beauty and health

To learn more about glutathione therapy and supplementation and how it could help you stay healthy, book an appointment online or over the phone with the team at Advanced Medical Care today.

The provider brings dosing knowledge